Table 1.
Patient baseline characteristics.
| Characteristics | Active arm (n = 49) | Control arm (n = 48) |
|---|---|---|
| Age (years) | ||
| Median | 62 | 63 |
| Range | 42–72 | 43–72 |
| Sex | ||
| Male | 38 | 37 |
| Female | 11 | 11 |
| ECOG performance status | ||
| Grade 0 | 25 | 26 |
| Grade 1 | 12 | 11 |
| Grade 2 | 12 | 11 |
| Stage at study entry | ||
| Stage IIIB | 25 | 25 |
| Stage IV | 24 | 23 |
| Pathology | ||
| Squamous cell carcinoma | 24 | 25 |
| Adenocarcinoma | 23 | 23 |
| EGFR in Adenocarcinoma | 2 | 0 |
| EGFR in Adenocarcinoma | ||
| EGFR(−) | 13 | 6 |
| EGFR(+) | 10 | 17 |
| Smoking status | ||
| Current | 3 | 4 |
| Prior | 36 | 33 |
| Never | 10 | 11 |
| Unknown | 0 | 0 |
| Reason for failure of last anticancer therapy | ||
| Refractory | 45 | 43 |
| Intolerant | 4 | 5 |
ECOG: Eastern Cooperative Oncology Group.